Netviewer AG: Online Meetings Now for Free
26.2.2009 11:21:25 CET | Business Wire | Press release
The Netviewer Web conferencing solution is now available for free to private users
Netviewer AG: Online Meetings Now for Free
More and more people are discovering the value of Web conferencing as a rapid and practical way to collaborate over great distances. German-based Netviewer AG is encouraging this trend by allowing private users to take advantage of its Web conferencing software for free. The offer is effective immediately. Users can obtain the fully functional program by downloading it from www.netviewer.com . Up to four people can jointly view and edit documents across great distances. The software is ideal for holding meetings or providing support. The free version is limited to private usage.
The ability to collaborate spontaneously is one of the reasons why Web meetings are so popular. The initiator of a meeting sends an e-mail invitation to other participants. The participants simply click on a link in the invitation and seconds later they can view the other person's screen. Software installation is not necessary. During a Web conference all participants can jointly view and edit documents, tables, and presentations. By changing the "Direction of viewing" each participant can lead a discussion by sharing files located on his or her computer. Functions like "Remote Control" enable the participants to make changes on the other person's computer. As a result, users are able to provide each other with rapid assistance in solving technical problems.
"Web conferences let you reach short-term decisions, save critical time, and vastly improve your efficiency no matter where in the world your partners are located," explains Dr. Andreas Schweinbenz, Founder and CEO of Netviewer. According to Dr. Schweinbenz, providing Netviewer Meet for free will increase awareness of the software: “We are confident that many of the new users will recognize the benefits of Web conferencing and purchase a license for business purposes." Netviewer solutions Meet, Support, and Remote are available starting at 29.90 € per month. These programs make it easy for small and large companies alike to collaborate with employees, vendors, and partners located at disparate locations, thereby helping them save time and reduce travel expenses.
Additional links:
Web conferencing: http://en.wikipedia.org/wiki/Web_conferencing
Prices for commercial use of Netviewer: http://www.netviewer.net/produkte/produktueberblick/
About Netviewer:
Netviewer AG (www.netviewer.com ) is the leading European manufacturer and provider of Web conferencing solutions. Founded in 2001 in Karlsruhe, Germany, today the company employs more than 200 people at seven locations around the world. Netviewer gives Internet users a live view of a partner's screen so that text, spreadsheets, graphics, and other documents can be jointly discussed and edited. Visual real-time communication over the Internet significantly reduces travel time and costs while increasing productivity.
More than 15,000 corporations and medium-sized companies in 55 countries use Netviewer software, including Bayer, BMW, Deutsche Post, Ernst & Young, SAP, Siemens, and Swisscom. The company is headquartered in Karlsruhe, Germany with subsidiaries in Switzerland, France, Great Britain, The Netherlands, Austria, and Sweden.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Contact:
Netviewer AG
Dunja Riehemann
Tel.: +49 (0)721-35 44 99-114
E-mail:
presse@netviewer.de
www.netviewer.com
or
Storymaker
Agentur für Public Relations GmbH
Katrin Renner
Tel.: +49
(0)7071-93872-28
E-mail: k.renner@storymaker.de
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom